FINWIRES · TerminalLIVE
FINWIRES

Budweiser APAC's Profit Slips in Q1 as China Spend Weighs; Shares Rise Nearly 2%

作者

-- Budweiser Brewing Company APAC (HKG:1876) posted a slight decline in profit attributable to equity holders in the first quarter as revenue fell despite a marginal increase in volumes.

The brewer reported profit attributable to equity holders of $226 million for the three months ended March 31, compared with $234 million a year earlier, according to a Tuesday Hong Kong bourse filing.

Earnings per share declined to $1.68 from $1.76 a year earlier, though it came in well above the Visible Alpha consensus estimate of $0.02.

Revenue fell 0.7% to $1.49 billion, topping the Visible Alpha estimate of $1.44 billion, while revenue per hectoliter declined 0.8% due to increased investments in China.

Analysts at Jefferies said sales were 3% above estimates, supported by both East and West, led by stronger India volumes.

India delivered strong double-digit growth in both volumes and revenue, supported by continued premiumization across its portfolio.

In China, volumes declined 1.5%, though the pace of decline narrowed, while revenue fell 4% amid increased investments in channels and brand activation.

The increased investments in China were mainly directed toward supporting wholesalers, expanding the in-home route-to-market and online-to-offline (O2O) channels, and stepping up brand and marketing initiatives.

This included higher spending on campaigns such as the nationwide rollout of Budweiser Magnum, supported by a partnership with Erling Haaland and the FIFA World Cup platform.

In South Korea, volumes declined by low-teens while revenue fell by mid-single-digits against a high base, reflecting shipment phasing ahead of a price increase in April 2025.

Separately, the company flagged ongoing legal and tax-related issues at its South Korean unit, Oriental Brewery, which has recorded $86 million in cumulative exceptional charges linked to customs audit claims that it is contesting.

The matter escalated in 2025 with indictments tied to alleged embezzlement, commercial bribery, and customs tax issues related to malt imports.

Several entities and senior executives were also named as joint defendants, with proceedings ongoing.

The subsidiary has also received tax assessments totaling about $71 million from Korean authorities for prior years and has prepaid around $62 million while it challenges portions of the claims.

"We believe investors will focus on: 1) strategy in China; 2) raw material cost trends and margin outlook; 3) price hike potential in APAC East amid a soft industry; and 4) potential in India," said Jefferies analysts in a note to clients.

Shares of Budweiser APAC were up marginally in Tuesday morning trade.

相關文章

Asia

Smartgroup對澳洲政府決定將電動車折扣維持一年表示歡迎,股價創兩年新高。

Smartgroup(ASX:SIQ)週二發表聲明,對澳洲政府決定將電動車購車折扣政策延長一年表示歡迎。 該公司指出,這項政策為充電產業提供了確定性,支持對澳洲充電基礎設施的進一步投資,並有助於建立電動車普及所需的充電網路。 受此消息提振,Smartgroup股價在近期交易中上漲7%,創下兩年來的新高。

$ASX:SIQ
Asia

市場傳聞:澳洲航空CEO對燃油供應前景“更加樂觀”

根據彭博新聞週二報道,澳航(ASX:QAN)執行長瓦妮莎·哈德森表示,公司對燃油供應前景「更加樂觀」。 報告稱,哈德森在麥格理澳洲會議上表示,公司已簽訂燃油供應協議,直到6月中旬。 哈德森指出,儘管燃料價格高企,但澳航的國內和國際航空旅行需求依然強勁。 (市場動態新聞來自與全球市場專業人士的對話。這些資訊被認為來自可靠來源,但可能包含傳聞和推測。準確性無法保證。)

$ASX:QAN
Asia

Sigma Healthcare宣布,旗下Chemist Warehouse品牌將根據與某藥房集團達成的協議進入英國市場;股價上漲4%。

Sigma Healthcare(ASX:SIG)週二宣布與Greenlight Healthcare簽署諒解備忘錄,根據該備忘錄,Chemist Warehouse品牌將進入英國市場。 該公司在聲明中表示,將收購這家員工持股的藥局集團旗下多家門市75%的股份,Greenlight將繼續持有剩餘的25%股份。 Sigma將獲得Chemist Warehouse品牌和智慧財產權的授權,並提供零售支援;Greenlight將提供配藥和專業服務以及後台支援。 合資企業的第一階段將專注於品牌重塑,並首先開發最多五家門市,第一家門市將位於倫敦市東北部的霍克斯頓街。如果第一階段成功,第二階段可能會開發更多門市。雙方計劃確定現有的Greenlight藥房,並在適當情況下將其改造或搬遷至Chemist Warehouse門市。 Sigma Healthcare的股票在周二的近期交易中上漲了近4%。

$ASX:SIG